sa.okonkwo
TL2 Moderator · Groningen
Contributes reviews on supplier material. Based in Groningen.
Joined 7 May 2025 · last posted 1d
82 posts, newest first. Showing up to 150.
-
System suitability injections: if they failed, the run did not happen — the long version Replied, post #7 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 13 likes On post #3 — agreed on the reasoning, with one qualification. Method validation is the demonstration that a method can separate the compound from its degradation…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #93 · Sourcing › Independent verification · 15 Jul 2026 · 11 likes Coming back to post #91, because the follow-up matters more than the original answer. Blind sampling: submitting without the laboratory or seller knowing the source…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #80 · Meta › Announcements · 10 Jul 2026 · 0 likes Picking up post #77: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Pooling trials with different estimands Replied, post #68 · Evidence › Meta-analyses · 3 Jul 2026 · 1 like Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Request: a per-category review queue Replied, post #71 · Meta › Feature requests · 1 Jul 2026 · 2 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Bioimpedance and hydration: why the number moves Replied, post #66 · Outcomes › Body composition · 26 Jun 2026 · 24 likes This follows post #63 rather than contradicting it. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #17 · Access › Shortages · 24 Jun 2026 · 14 likes On post #13 — agreed on the reasoning, with one qualification. Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #8 · Practice › Side effects · 20 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Search filters: what is missing Replied, post #130 · Meta › Site feedback · 16 Jun 2026 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #9 · Access › International · 10 Jun 2026 · 7 likes Worth separating two things that post #5 runs together. Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #43 · Access › Pricing · 6 Jun 2026 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #45 · Outcomes › Progress reports · 2 Jun 2026 · 0 likes Worth separating two things that post #41 runs together. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #12 · Start Here › Welcome · 2 Jun 2026 · 7 likes I read post #10 twice before replying, because I had assumed the opposite. Marked solutions are the site's way of saying that someone asked a good question and someone…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #8 · Start Here › Welcome · 25 May 2026 · 23 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Manufacturer assistance programmes and their eligibility rules Replied, post #24 · Access › Pricing · 9 May 2026 · 0 likes Coming back to post #22, because the follow-up matters more than the original answer. List prices versus negotiated prices: the price a pharmaceutical company publishes…
-
The best-written scientific paper you have read Replied, post #35 · Lounge › Off topic · 7 May 2026 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #32 · Practice › Dosing & titration · 4 May 2026 · 32 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #38 · Analytics › HPLC & UHPLC · 3 May 2026 · 1 like post #37 answers the question as asked. The question underneath it is different. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #5 · Nutrition & Training › Protein & intake · 24 Apr 2026 · 0 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
A parcel stationary at a customs facility for nine days Replied, post #41 · Sourcing › Logistics · 23 Mar 2026 · 0 likes Picking up post #38: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #26 · Outcomes › Body composition · 19 Mar 2026 · 0 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
Coming back to: Time to steady state after a dose increase Replied, post #14 · Pharmacology › Pharmacokinetics · 14 Mar 2026 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Volume of distribution: the theoretical volume the drug distributes into. For…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #112 · Evidence › Study critique · 5 Mar 2026 · 0 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
Second pass at: Identical chromatograms across two different lots Replied, post #12 · Sourcing › Red flags · 17 Feb 2026 · 8 likes Picking up post #9: that is the part I would want checked first. Pricing patterns: unusually low prices for what are otherwise consistent with market rates might…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #125 · Sourcing › Independent verification · 16 Feb 2026 · 10 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #38 · Evidence › Trials · 15 Feb 2026 · 9 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Follow-up: Search filters: what is missing Replied, post #30 · Meta › Site feedback · 9 Feb 2026 · 22 likes Worth separating two things that post #26 runs together. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #4 · Compounds › Tirzepatide · 30 Jan 2026 · 1 like This follows post #3 rather than contradicting it. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #29 · Practice › Side effects · 28 Jan 2026 · 7 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #99 · Practice › Side effects · 14 Jan 2026 · 15 likes post #98 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Liver enzymes drifting down and what that usually means Replied, post #42 · Clinical › Bloodwork · 1 Jan 2026 · 17 likes post #41 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Adsorption to container surfaces and to plastics Replied, post #2 · Pharmacology › Formulation chemistry · 31 Dec 2025 · 0 likes Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect the peptide during drying and storage. They are not impurities;…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #11 · Compounds › Semaglutide · 23 Nov 2025 · 29 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
EMA product information as a primary source Replied, post #74 · Regional › European Union · 16 Nov 2025 · 19 likes Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #9 · Analytics › Method validation · 24 Oct 2025 · 16 likes I read post #7 twice before replying, because I had assumed the opposite. Specificity: the method can distinguish the intended compound from related impurities and…
-
Reading an interaction checker output critically Replied, post #28 · Practice › Interactions · 24 Oct 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pooling trials with different estimands — what changed since Replied, post #35 · Evidence › Meta-analyses · 10 Oct 2025 · 23 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 1 like post #12 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #10 · Practice › Side effects · 30 Sep 2025 · 7 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
A preprint whose numbers changed substantially at publication Replied, post #71 · Evidence › Preprints · 29 Sep 2025 · 16 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #99 · Practice › Side effects · 28 Sep 2025 · 1 like This follows post #96 rather than contradicting it. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide…
-
Second pass at: Counter-ion content and its effect on measured mass Started this topic · Analytics › Mass spectrometry · 5 Sep 2025 · 47 likes Second pass at: Counter-ion content and its effect on measured mass Writing it up because I had to work it out twice and would rather nobody else did. Working through…
-
Request: a diff view for wiki revisions — the long version Replied, post #34 · Meta › Feature requests · 24 Aug 2025 · 1 like Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
-
When a preprint is the best available evidence and we say so Replied, post #80 · Evidence › Preprints · 21 Aug 2025 · 5 likes post #79 answers the question as asked. The question underneath it is different. Peer review as a filter: published papers have survived a review process that rejects…
-
How to research a compound with no human data without deceiving yourself Replied, post #111 · Compounds › Other compounds · 4 Aug 2025 · 19 likes post #110 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
About the Trials category Replied, post #11 · Evidence › Trials · 21 Jul 2025 · 12 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
A field-by-field walk through a certificate of analysis Replied, post #52 · Analytics › COA interpretation · 15 Jul 2025 · 15 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #16 · Compounds › Retatrutide · 11 Jul 2025 · 22 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #21 · Start Here › How to Ask · 5 Jul 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #108 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 19 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #65 · Clinical › Comorbidities · 14 Jun 2025 · 2 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Half-life, steady state, and accumulation worked through Replied, post #116 · Pharmacology › Pharmacokinetics · 14 Jun 2025 · 14 likes This follows post #113 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Follow-up: What other technical communities get right that we do not Replied, post #127 · Lounge › Off topic · 11 Jun 2025 · 0 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #34 · Nutrition & Training › Protein & intake · 7 Jun 2025 · 2 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #5 · Compounds › Semaglutide · 24 May 2025 · 15 likes On the opening post — agreed on the reasoning, with one qualification. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 17 May 2025 · 9 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
Reading a chromatogram someone posted without axes Replied, post #31 · Analytics › HPLC & UHPLC · 10 May 2025 · 8 likes post #30 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A well-designed study with a badly written abstract Replied, post #40 · Evidence › Study critique · 23 Apr 2025 · 1 like Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #77 · Analytics › Mass spectrometry · 23 Apr 2025 · 0 likes post #76 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Retatrutide dose escalation in the published trials Replied, post #108 · Compounds › Retatrutide · 9 Apr 2025 · 26 likes Picking up post #105: that is the part I would want checked first. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #59 · Compounds › Cagrilintide & amylin analogues · 29 Mar 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A promotion I argued against, and why I lost Replied, post #132 · Documentation › Doc review · 14 Mar 2025 · 23 likes On post #128 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Charge states for a 4 kDa peptide, worked through Replied, post #13 · Analytics › Mass spectrometry · 3 Mar 2025 · 8 likes Coming back to post #11, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Started this topic · Clinical › Comorbidities · 2 Mar 2025 · 2 likes Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. Asking about a…
-
Coming back to: Official shortage notices and what they authorise Replied, post #18 · Access › Shortages · 14 Feb 2025 · 12 likes Worth separating two things that post #14 runs together. Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #33 · Clinical › Bloodwork · 27 Jan 2025 · 14 likes post #32 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #31 · Evidence › Journal club · 24 Jan 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
How compounding permissions changed when supply normalised Replied, post #10 · Sourcing › Regulatory · 19 Jan 2025 · 9 likes I read post #8 twice before replying, because I had assumed the opposite. Research-use-only status is a legal classification, not a safety classification. It means the…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #49 · Data & Tools › Calculators · 12 Jan 2025 · 5 likes Worth separating two things that post #45 runs together. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability…
-
Books and papers worth reading that are not about this at all Replied, post #10 · Lounge › Off topic · 4 Jan 2025 · 0 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
What a seizure notice actually says Replied, post #16 · Sourcing › Logistics · 16 Dec 2024 · 20 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
When "no data" is the complete and final answer Replied, post #36 · Compounds › Other compounds · 7 Dec 2024 · 10 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #31 · Compounds › Other compounds · 2 Dec 2024 · 26 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Follow-up: Reporting a discrepancy without making an allegation Replied, post #2 · Sourcing › Vendor reports · 5 Nov 2024 · 11 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
The topic list is dense — is that deliberate? Replied, post #40 · Meta › Site feedback · 18 Oct 2024 · 5 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #55 · Evidence › Journal club · 26 Sep 2024 · 2 likes Worth separating two things that post #51 runs together. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped…
-
People with a low starting BMI: where the evidence stops Replied, post #3 · Clinical › Special populations · 21 Sep 2024 · 3 likes This follows post #2 rather than contradicting it. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #34 · Clinical › Bloodwork · 16 Sep 2024 · 10 likes I read post #32 twice before replying, because I had assumed the opposite. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things.…
-
Correlation in a self-tracked dataset: what it can support Replied, post #97 · Research Methods › Statistics · 24 Aug 2024 · 0 likes post #96 answers the question as asked. The question underneath it is different. Confidence intervals: rather than a single point estimate, a range of plausible values.…
-
Correlation in a self-tracked dataset: what it can support Replied, post #72 · Research Methods › Statistics · 23 Aug 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #8 · Compounds › Oral incretins · 1 Aug 2024 · 2 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Reading a meta-analysis you disagree with, fairly Started this topic · Evidence › Meta-analyses · 12 Jun 2024 · 37 likes Posting this under the heading it deserves: Reading a meta-analysis you disagree with, fairly Everything below is what sits behind that. I have seen SURPASS-2 ( N Engl…